Fig 3. Survival analysis for 180-day transplant-free survival in AD/ACLFIND stratified by clinical parameters.
Survival analysis by the Kaplan-Meier method of patients with their first indexed AD/ACLF induced by any indeterminate factors (AD/ACLFIND) stratified by levels of serum total bilirubin (panel A), serum sodium (panel B), and white blood cell counts (panel C) are shown. The survival curves of AD/ACLFBAC are also demonstrated for comparison. P-values analyzed by log-rank tests are shown. *P < 0.05; **P < 0.01; ***P < 0.0001.